Keeping data secure and giving individuals more control

9 August 2016
victoria-hordern-big

In our weekly expert view piece, Victoria Hordern, privacy and cybersecurity lawyer at Hogan Lovells, examines the UK government's proposals on data security and data sharing in the health sector.

From a data protection and data security perspective, data in the health sector in the UK has appeared particularly vulnerable over the years. Reports from the UK's Information Commissioner's Office (ICO) on data security incident trends have repeatedly highlighted that the health sector experiences the most breaches. Reasons for that include the size of the health sector, the sensitivity of the data and the mandatory requirement within the UK government to report breaches to the ICO.

As all industries and the public sector increasingly digitise their processes, the government has indicated a renewed focus on data security and data sharing and, on 6 July, published two independent reviews concerning data security and data sharing in the health and care system in England. The two independent reviews are the:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical